Abstract
Follicular lymphoma (FL) B cells contract tight connections with their microenvironment, which governs the pathogenesis and progression of the disease. Indeed, specific immune response gene signatures, obtained from whole biopsy samples, have been associated with patient survival. In this study, we performed gene expression profiling of purified B cell and non-B cell compartments obtained from FL and reactive lymph nodes. We identified 677 non-redundant genes defining the FL interface and involving 26 FL-specific functional networks. This approach highlighted an interleukin-4 (IL-4)-centered pathway associated with an activation of signal transducer and activator of transcription 6 (STAT6), which favors overexpression of IL-4-target genes. In addition, FL microenvironment was characterized by a strong enrichment in follicular helper T cells (TFH), as demonstrated through transcriptomic and flow cytometry analyses. The majority of phospho-STAT6pos B cells were located at the vicinity of cells expressing the programmed death 1 (PD-1) TFH marker. Moreover, purified FL-derived TFH, expressed IL4 at very high levels compared with purified tonsil-derived TFH or non-TFH microenvironment. Altogether, our study demonstrated that tumor-infiltrating TFH specifically express functional IL-4 in FL, creating an IL-4-dependent TFH–B cell axis. This cross talk could sustain FL pathogenesis and represent a new potential therapeutic target.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bende RJ, Smit LA, Noesel CJ . Molecular pathways in follicular lymphoma. Leukemia 2007; 21: 18–29.
Roulland S, Navarro JM, Grenot P, Milili M, Agopian J, Montpellier B et al. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J Exp Med 2006; 203: 2425–2431.
Ame-Thomas P, Maby-El Hajjami H, Monvoisin C, Jean R, Monnier D, Caulet-Maugendre S et al. Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis. Blood 2007; 109: 693–702.
Travert M, Ame-Thomas P, Pangault C, Morizot A, Micheau O, Semana G et al. CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and upregulation of c-FLIP and Bcl-xL. J Immunol 2008; 181: 1001–1011.
Nurieva RI, Chung Y, Hwang D, Yang XO, Kang HS, Ma L et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008; 29: 138–149.
King C, Tangye SG, Mackay CR . T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu Rev Immunol 2008; 26: 741–766.
Ma CS, Suryani S, Avery DT, Chan A, Nanan R, Santner-Nanan B et al. Early commitment of naive human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12. Immunol Cell Biol 2009; 87: 590–600.
Lee AM, Clear AJ, Calaminici M, Davies AJ, Jordan S, MacDougall F et al. Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. J Clin Oncol 2006; 24: 5052–5059.
Byers RJ, Sakhinia E, Joseph P, Glennie C, Hoyland JA, Menasce LP et al. Clinical quantitation of immune signature in follicular lymphoma by RT–PCR-based gene expression profiling. Blood 2008; 111: 4764–4770.
Carreras J, Lopez-Guillermo A, Fox BC, Colomo L, Martinez A, Roncador G et al. High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 2006; 108: 2957–2964.
Carreras J, Lopez-Guillermo A, Roncador G, Villamor N, Colomo L, Martinez A et al. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J Clin Oncol 2009; 27: 1470–1476.
Glas AM, Knoops L, Delahaye L, Kersten MJ, Kibbelaar RE, Wessels LA et al. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol 2007; 25: 390–398.
Farinha P, Masoudi H, Skinnider BF, Shumansky K, Spinelli JJ, Gill K et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood 2005; 106: 2169–2174.
Alvaro T, Lejeune M, Salvado MT, Lopez C, Jaen J, Bosch R et al. Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. J Clin Oncol 2006; 24: 5350–5357.
Taskinen M, Karjalainen-Lindsberg ML, Leppa S . Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP. Blood 2008; 111: 4664–4667.
Canioni D, Salles G, Mounier N, Brousse N, Keuppens M, Morchhauser F et al. High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. J Clin Oncol 2008; 26: 440–446.
de Jong D, Koster A, Hagenbeek A, Raemaekers J, Veldhuizen D, Heisterkamp S et al. Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols. Haematologica 2009; 94: 70–77.
Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004; 351: 2159–2169.
Glas AM, Kersten MJ, Delahaye LJ, Witteveen AT, Kibbelaar RE, Velds A et al. Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood 2005; 105: 301–307.
Harjunpaa A, Taskinen M, Nykter M, Karjalainen-Lindsberg ML, Nyman H, Monni O et al. Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP. Br J Haematol 2006; 135: 33–42.
Carbonnelle-Puscian A, Copie-Bergman C, Baia M, Martin-Garcia N, Allory Y, Haioun C et al. The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages. Leukemia 2009; 23: 952–960.
Calvo KR, Dabir B, Kovach A, Devor C, Bandle R, Bond A et al. IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma. Blood 2008; 112: 3818–3826.
Schaffer A, Kim EC, Wu X, Zan H, Testoni L, Salamon S et al. Selective inhibition of class switching to IgG and IgE by recruitment of the HoxC4 and Oct-1 homeodomain proteins and Ku70/Ku86 to newly identified ATTT cis-elements. J Biol Chem 2003; 278: 23141–23150.
Lu X, Nechushtan H, Ding F, Rosado MF, Singal R, Alizadeh AA et al. Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas. Blood 2005; 105: 2924–2932.
King IL, mohrs M . IL-4-producing CD4+ T cells in reactive lymph nodes during helminth infection are T follicular helper cells. J Exp Med 2009; 206: 1001–1007.
Reinhardt RL, Liang HE, Locksley RM . Cytokine-secreting follicular T cells shape the antibody repertoire. Nat Immunol 2009; 10: 385–393.
Zaretsky AG, Taylor JJ, King IL, Marshall FA, Mohrs M, Pearce EJ . T follicular helper cells differentiate from Th2 cells in response to helminth antigens. J Exp Med 2009; 206: 991–999.
Rasheed AU, Rahn HP, Sallusto F, Lipp M, Muller G . Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4T cells and is independent of CD57 expression. Eur J Immunol 2006; 36: 1892–1903.
Brachtel EF, Washiyama M, Johnson GD, Tenner-Racz K, Racz P, MacLennan IC . Differences in the germinal centres of palatine tonsils and lymph nodes. Scand J Immunol 1996; 43: 239–247.
Allen CD, Ansel KM, Low C, Lesley R, Tamamura H, Fujii N et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol 2004; 5: 943–952.
Husson H, Carideo EG, Neuberg D, Schultze J, Munoz O, Marks PW et al. Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood 2002; 99: 282–289.
Guiter C, Dusanter-Fourt I, Copie-Bergman C, Boulland ML, Le Gouvello S, Gaulard P et al. Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. Blood 2004; 104: 543–549.
Skinnider BF, Elia AJ, Gascoyne RD, Patterson B, Trumper L, Kapp U et al. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed–Sternberg cells of Hodgkin lymphoma. Blood 2002; 99: 618–626.
Wurster AL, Rodgers VL, White MF, Rothstein TL, Grusby MJ . Interleukin-4-mediated protection of primary B cells from apoptosis through Stat6-dependent upregulation of Bcl-xL. J Biol Chem 2002; 277: 27169–27175.
Schmitter D, Koss M, Niederer E, Stahel RA, Pichert G . T-cell derived cytokines co-stimulate proliferation of CD40-activated germinal centre as well as follicular lymphoma cells. Hematol Oncol 1997; 15: 197–207.
Baus D, Nonnenmacher F, Jankowski S, Doring C, Brautigam C, Frank M et al. STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line. Leukemia 2009; 23: 1885–1893.
Davies AJ, Rosenwald A, Wright G, Lee A, Last KW, Weisenburger DD et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol 2007; 136: 286–293.
Lu X, Chen J, Malumbres R, Cubedo Gil E, Helfman DM, Lossos IS . HGAL, a lymphoma prognostic biomarker, interacts with the cytoskeleton and mediates the effects of IL-6 on cell migration. Blood 2007; 110: 4268–4277.
Hagemann T, Biswas SK, Lawrence T, Sica A, Lwis CE . Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB. Blood 2009; 113: 3139–3146.
Peuchmaur M, Emilie D, Crevon MC, Brousse N, Gaulard P, D’Agay MF et al. Interleukin-2 and interferon-gamma production in follicular lymphomas. Am J Clin Pathol 1991; 95: 55–62.
Maby-El Hajjami H, Ame-Thomas P, Pangault C, Tribut O, DeVos J, Jean R et al. Functional alteration of the lymphoma stromal cell niche by the cytokine context: role of indoleamine-2,3 dioxygenase. Cancer Res 2009; 69(7): 3228–3237.
Warzocha K, Ribeiro P, Renard N, Bienvenu J, Charlot C, Coiffier B et al. Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas. Cancer Immunol Immunother 2000; 49: 469–475.
Salles G, Bienvenu J, Bastion Y, Barbier Y, Doche C, Warzocha K et al. Elevated circulating levels of TNFalpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients. Br J Haematol 1996; 93: 352–359.
Anichini A, Mortarini R, Romagnoli L, Baldassari P, Cabras A, Carlo-Stella C et al. Skewed T-cell differentiation in patients with indolent non-Hodgkin lymphoma reversed by ex vivo T-cell culture with gammac cytokines. Blood 2006; 107: 602–609.
Zangani MM, Froyland M, Qiu GY, Meza-Zepeda LA, Kutok JL, Thompson KM et al. Lymphomas can develop from B cells chronically helped by idiotype-specific T cells. J Exp Med 2007; 204: 1181–1191.
Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, Shen M et al. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 2006; 107: 4101–4108.
Fazilleau N, Mark L, McHeyzer-Williams LJ, McHryzer-Willams MG . Follicular helper T cells: lineage and location. Immunity 2009; 30: 324–335.
Marafioti T, Paterson JC, Ballabio E, Chott A, Natkunam Y, Rodriguez-Justo M et al. The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation. Haematologica 2010; 95: 432–439.
de Leval L, Rickman DS, Thielen C, Reynies A, Huang YL, Delsol G et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 2007; 109: 4952–4963.
Takaki H, Ichiyama K, Koga K, Chinen T, Takaesu G, Sugiyama Y et al. STAT6 Inhibits TGF-beta1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor. J Biol Chem 2008; 283: 14955–14962.
Pillemer BB, Qi Z, Melgert B, Oriss TB, Ray P, Ray A . STAT6 activation confers upon T helper cells resistance to suppression by regulatory T cells. J Immunol 2009; 183: 155–163.
Acknowledgements
This study was supported by research fundings from the Institut National du Cancer (INCa libre 2005—PL070), the Association pour la Recherche Contre le Cancer (ARC AO 2007), the Ligue Régionale contre le Cancer (AO 2004) and the Association pour le Développement de l’Hémato-Oncologie (ADHO). DR is supported by an INCa fellowship. We thank the ‘Centre de Ressources (CRB)-Santé‘ of Rennes’ hospital, Patrick Tas and Jean-Michel Picquenot for providing non-malignant and follicular lymph nodes, Christophe Ruaux for providing tonsil samples, and the ‘Institut Fédératif de Recherche (IFR)-140’ of Rennes’University for cell sorting core facility.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Pangault, C., Amé-Thomas, P., Ruminy, P. et al. Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH–B cell axis. Leukemia 24, 2080–2089 (2010). https://doi.org/10.1038/leu.2010.223
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2010.223
Keywords
This article is cited by
-
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling
Nature (2024)
-
CD23-positive, BCL2-Rearrangement-negative Keimzentrumslymphome
Die Pathologie (2023)
-
Insights into the tumor microenvironment of B cell lymphoma
Journal of Experimental & Clinical Cancer Research (2022)
-
PARP14 is a novel target in STAT6 mutant follicular lymphoma
Leukemia (2022)
-
CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells
Nature Communications (2021)